The Role of Dapagliflozin in Reducing Anthracycline-Induced Cardiotoxicity in Type 2 Diabetes Mellitus Patients with Breast Cancer
El Merry, M., Abdellah, A., Soliman, M., Greash, M., Nada, F. (2025). The Role of Dapagliflozin in Reducing Anthracycline-Induced Cardiotoxicity in Type 2 Diabetes Mellitus Patients with Breast Cancer. EKB Journal Management System, 28(3), 1-8. doi: 10.21608/scumj.2025.418495
Mohammed Ahmed El Merry; Ahmed Tageldien Abdellah; Muhammad Soliman; Mohamed Greash; Fathy A. Nada. "The Role of Dapagliflozin in Reducing Anthracycline-Induced Cardiotoxicity in Type 2 Diabetes Mellitus Patients with Breast Cancer". EKB Journal Management System, 28, 3, 2025, 1-8. doi: 10.21608/scumj.2025.418495
El Merry, M., Abdellah, A., Soliman, M., Greash, M., Nada, F. (2025). 'The Role of Dapagliflozin in Reducing Anthracycline-Induced Cardiotoxicity in Type 2 Diabetes Mellitus Patients with Breast Cancer', EKB Journal Management System, 28(3), pp. 1-8. doi: 10.21608/scumj.2025.418495
El Merry, M., Abdellah, A., Soliman, M., Greash, M., Nada, F. The Role of Dapagliflozin in Reducing Anthracycline-Induced Cardiotoxicity in Type 2 Diabetes Mellitus Patients with Breast Cancer. EKB Journal Management System, 2025; 28(3): 1-8. doi: 10.21608/scumj.2025.418495